Dose escalation study of no-carrier-added 131I-metaiodobenzylguanidine for relapsed or refractory neuroblastoma: new approaches to neuroblastoma therapy consortium trial - Matthay, K K; Weiss, B; Villablanca, J G (J Nucl Med, 2012)
et al.